Info

Professor Bob Pinedo awarded

Professor Bob Pinedo awarded

Professor Bob Pinedo, member of the CTMM Supervisory Board, has been awarded with the K. Dornbush Award 2012.

We congratulate Prof. dr. Bob Pinedo, member of the CTMM Supervisory Board, who has been awarded with the K. Dornbush Award 2012 by the Netherlands-America Foundation.

The ceremony will take place during the annual Gala Awards Dinner on May 11 in Arlington, Virginia.

The award is named after former U.S. ambassador in the Netherlands, Terry Dornbush and is intended for a person who strengthened the relationship between the two countries in the field of philanthropy, education and culture.

"Professor Pinedo is not only distinguished for his role in the training of doctors, but also for his leading role in the fight against cancer in both the U.S. and the Netherlands," said Dornbush. The Netherlands-America Foundation wants to strengthen the bond between the ten million Americans of Dutch origin and the Netherlands.

Output Booklets

If you want to see what 300 million euros of public-private partnership funding can achieve, take a look at the new set of output booklets that have been prepared for the individual CTMM projects.

Scientific breakthroughs, new products, patents, start-up companies, research infrastructures, PhD theses and academic papers, it's all there in black and white - proof that together we have achieved something truly remarkable and placed the Netherlands in a world leading position for translational medical research.

AIRFORCE - personalized chemotherapy against lung cancer

BIOCHIP - Diagnosing leukemia sub-types

Breast CARE - Predicting therapy response in breast cancer patients

DeCoDe - Early diagnosis of colorectal cancer

HIFU-CHEM - More chemo where it should be

MUSIS - Check removal of tumor tissue during surgery

PCMM - Limit over-diagnosis and over-treatment in prostate cancer

VOLTA - Remove tumors through local heating

Circulating Cells - investigating white blood cells and platelets for discriminating patients with increased risk of developing unstable plaques

Eminence - developing multiple diagnostic technologies to detect neovascularization and stratifying patients

INCOAG - developing a new set of tests to estimate the risk of thrombosis

Parisk - how to predict risk of rupture of an individual plaque

Predicct - focusing on early diagnoses and treatment of Diabetes DM2

Triumph - identifying biomarkers for cardiac failure

LeARN - finding an early diagnosis of Alzheimer's Disease

AmpVacs - a new vaccine technology platform in the combat against conserved influenza A determinants

MARS - tools to provide rapid and accurate information about an individual patient suffering from sepsis

TRACER - patient-tailored treatment of Rheumatoid Arthritis

Health Technology Assessment (HTA)

TraIT - establishing an easy-to-access and easy-to-use infrastructure for sharing of research data, and set of tools for researchers to interact with and explore a unified translational medical research space

March 2017